OBJECTIVES: It is known that liver disease can cause an imbalance in the coagulation
system, but available data on liver disease and risk of venous thromboembolism are …

Background—Studies on long-term mortality after venous thromboembolism (VTE) are
sparse. Methods and Results—Using Danish medical databases, we conducted a 30-year …

Objectives Fluconazole is widely used for the treatment of candidiasis. Although the drug is
also prescribed to pregnant women, data on the safety of use of fluconazole during …

Background Sepsis and severe sepsis are common conditions in hospital settings, and are
associated with high rates of morbidity and mortality, but reported incidences vary …

Background: Pericarditis may be a serious complication of malignancy. Its significance as a
first symptom of occult cancer and as a prognostic factor for cancer survival is unknown …

Introduction Splanchnic vein thrombosis (SVT) is a rare condition with a poorly understood
prognosis. Materials and methods We conducted a population-based cohort study (1994 …

OBJECTIVES: Patients with cirrhosis are at increased risk of venous thromboembolism
(VTE), but the impact of cirrhosis on the clinical course following VTE is unclear. In a …

A link between sarcoidosis and malignancy was suggested by in 1972 Brincker [1], and
subsequently supported by several studies [2–6]. However, the existing studies have …

Purpose In patients surviving infective endocarditis (IE) recurrence of bacteremia or IE is
feared. However, knowledge is sparse on the incidence and risk factors for the recurrence of …

Background The use of 16S/18S rRNA targeted next-generation sequencing (tNGS) has
improved microbial diagnostics, however, the use of tNGS in a routine clinical setting …